XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,038,000 | +122.7% | 175,000 | 0.0% | 0.02% | +53.8% |
| Q2 2020 | $466,000 | +36.7% | 175,000 | 0.0% | 0.01% | -7.1% |
| Q1 2020 | $341,000 | -3.4% | 175,000 | +250.0% | 0.01% | +16.7% |
| Q4 2019 | $353,000 | -28.3% | 50,000 | 0.0% | 0.01% | -40.0% |
| Q3 2019 | $492,000 | -57.0% | 50,000 | -50.0% | 0.02% | -25.9% |
| Q2 2019 | $1,144,000 | +13.9% | 100,000 | 0.0% | 0.03% | -12.9% |
| Q1 2019 | $1,004,000 | – | 100,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|